Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

iShares Global Healthcare ETF

102.16
-0.1100-0.11%
Volume:1.37M
Turnover:139.66M
Market Cap:4.20B
PE:-99.35
High:102.35
Open:102.06
Low:101.31
Close:102.27
52wk High:107.69
52wk Low:85.36
Shares:41.10M
Float Shares:41.10M
Volume Ratio:10.89
T/O Rate:3.32%
Dividend:1.44
Dividend Rate:1.41%
EPS(TTM):-1.0283
EPS(LYR):-1.0283
ROE:-8.66%
ROA:0.90%
PB:1.08
PE(LYR):-99.35

Loading ...

OverviewCompanyNewsFilings

Wachtell Dealmaker Jumps to Linklaters to Bolster US Buildout

Reuters
·
Sep 10

Johnson & Johnson Announces R$ 0.3 Per Unit Dividend for 3Q 2026

Reuters
·
Sep 10

Eli Lilly is Maintained at Reduce by HSBC

Dow Jones
·
Sep 10

Eli Lilly’s GLP-1 Windfall to Fund Push into Women’s Health - Bloomberg News

Reuters
·
Sep 10

AbbVie Says Atogepant Met Primary, Secondary Endpoints in Phase 3 Menstrual Migraine Study

MT Newswires Live
·
Sep 10

AbbVie’s atogepant shows positive Phase 3 results in menstrual migraine

TIPRANKS
·
Sep 10

Abbvie - Atogepant Safety Results Consistent with Known Profile; no New Safety Signals

THOMSON REUTERS
·
Sep 10

Abbvie - Atogepant Meets Primary and All Eight Ranked Secondary Endpoints in Phase 3 Luna Study

THOMSON REUTERS
·
Sep 10

Abbvie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine

THOMSON REUTERS
·
Sep 10

Abbvie - Atogepant Shows Significant Improvements Across Multiple Endpoints Versus Placebo

THOMSON REUTERS
·
Sep 10

Johnson & Johnson receives CE Marking for ACUVUE OASYS MAX

TIPRANKS
·
Sep 10

Johnson & Johnson Receives Ce Marking for Acuvue Oasys Max Reusable Contact Lenses

THOMSON REUTERS
·
Sep 10

HSBC Adjusts Price Target on Eli Lilly and Co. to $940 From $850, Keeps Reduce Rating

MT Newswires Live
·
Sep 10

TPG weighs roughly $5B sale of Lyric, Reuters reports

TIPRANKS
·
Sep 10

'Cut Points' for 2027 Medicare Advantage Plans Look Neutral to Positive, Analysts Say

Reuters
·
Sep 10

Sector Update: Healthcare

MT Newswires Live
·
Sep 10

Merck Price Target Raised to $161.00/Share from $127.00 by Leerink Partners

Dow Jones
·
Sep 10

SHL Telemedicine Tightens Grip on Israeli Medical Centers With Mediton and Medishur Buyout

TIPRANKS
·
Sep 10

Top Midday Stories: Meta Launches Muse Personal AI Agent; Dow Said to Consider Exiting $20 Billion Chemicals JV With Saudi Aramco

MT Newswires Live
·
Sep 09

UnitedHealth Falls; Cites Pressure in Commercial Business

Reuters
·
Sep 09
More